Greenwich LifeSciences Expands Phase III FLAMINGO-01 Breast Cancer Trial to Ireland

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO...

September 19, 2025 | Friday | News
Kindeva Opens New UK Headquarters at Charnwood Campus to Advance Sustainable Inhaler Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park...

September 19, 2025 | Friday | News
Sartorius and IMT Open “Lab Space” in Brazil to Advance Biotechnology Training and Innovation

  Sartorius, a leading international partner of life science research and the biopharmaceutical industry,  announced the opening of its new appl...

September 19, 2025 | Friday | News
Ono Pharmaceutical and Deciphera Secure European Commission Approval for Vimseltinib (ROMVIMZA™) as First Therapy for TGCT in the EU

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co.,...

September 18, 2025 | Thursday | News
Crown Bioscience Expands US Footprint with New State-of-the-Art Model Development Center in Kannapolis, North Carolina

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corp...

September 18, 2025 | Thursday | News
Cenevo Launches Labguru Assistant to Bring AI-Driven Support Directly Into Scientists’ Daily Work

Cenevo is launching the Labguru Assistant, an AI-enabled extension to the Labguru solution designed to provide scientists with real-time, in-platform suppo...

September 18, 2025 | Thursday | News
Allot and SnapLogic Launch AI Agent to Tackle Health Inequalities Using Advanced Data Integration

New AI agent turns complex healthcare and environmental data into actionable insights for pharmaceutical teams. SnapLogic, the Agentic Integra...

September 17, 2025 | Wednesday | News
Thermo Fisher Scientific Launches Olink® Target 48 Neurodegeneration Panel for Absolute Quantification of Key Biomarkers

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world...

September 16, 2025 | Tuesday | News
uLab Systems and Biolux Technology Forge Strategic Partnership to Redefine Clear Aligner Therapy

uLab Systems®, a leader in digital orthodontic innovation, and Biolux Technology, creator of the OrthoPulse® near-infrared (NIR) light therapy de...

September 12, 2025 | Friday | News
Sapio Sciences and Ultima Genomics Forge Strategic Partnership to Streamline Multi-Omics Research

Sapio Sciences, the science-awareTM lab informatics platform,  announced a strategic partnership with Ultima Genomics. The collaboration will make m...

September 10, 2025 | Wednesday | News
Corner Therapeutics Unveils Breakthrough Hyperactivator Technology Showing Potential for a Universal Influenza Vaccine and Cancer Immunotherapy

Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, published research in mB...

September 09, 2025 | Tuesday | Reports
23andMe Research Institute, TWP, and Lifebit Launch Open-Source Data Platform for Lung Cancer Genetics Study

23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the...

September 08, 2025 | Monday | News
Daiichi Sankyo and Merck Report Positive Phase 2 Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 2...

September 08, 2025 | Monday | News
Biocodex Leads €55M Series B with €11M Strategic Investment in MRM Health to Advance Microbiome-Based Therapeutics

Biocodex, a French family-owned pharmaceutical pioneer in microbiota research for over 70 years, announces a strategic equity investment of €11 mill...

September 05, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close